Citigroup Inc Ligand Pharmaceuticals Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 25,580 shares of LGND stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,580

Previous 14,473 76.74%

Holding current value

$3.14 Million

Previous $1.22 Million 110.17%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$82.7 - $110.11 $918,548 - $1.22 Million	11,107 Added 76.74%	25,580 $2.56 Million
Q2 2024 Aug 12, 2024	BUY	$68.53 - $87.91 $82,989 - $106,459	1,211 Added 9.13%	14,473 $1.22 Million
Q1 2024 May 10, 2024	BUY	$68.64 - $89.2 $56,010 - $72,787	816 Added 6.56%	13,262 $969,000
Q4 2023 Feb 09, 2024	BUY	$49.57 - $72.63 $181,872 - $266,479	3,669 Added 41.8%	12,446 $888,000
Q3 2023 Nov 09, 2023	SELL	$58.86 - $72.67 $429,383 - $530,127	-7,295 Reduced 45.39%	8,777 $525,000
Q2 2023 Aug 10, 2023	BUY	$69.53 - $79.33 $255,592 - $291,617	3,676 Added 29.65%	16,072 $1.16 Million
Q1 2023 May 11, 2023	SELL	$65.67 - $77.08 $37,563 - $44,089	-572 Reduced 4.41%	12,396 $911,000
Q4 2022 Feb 09, 2023	SELL	$61.72 - $96.74 $1.81 Million - $2.84 Million	-29,394 Reduced 69.39%	12,968 $866,000
Q3 2022 Nov 10, 2022	BUY	$0.01 - $107.56 $57 - $615,565	5,723 Added 15.62%	42,362 $3.65 Million
Q2 2022 Aug 10, 2022	BUY	$74.52 - $117.06 $946,478 - $1.49 Million	12,701 Added 53.06%	36,639 $3.27 Million
Q1 2022 May 12, 2022	SELL	$94.99 - $151.56 $1.73 Million - $2.76 Million	-18,198 Reduced 43.19%	23,938 $2.69 Million
Q4 2021 Feb 10, 2022	BUY	$127.69 - $165.85 $817,854 - $1.06 Million	6,405 Added 17.93%	42,136 $6.51 Million
Q3 2021 Nov 10, 2021	BUY	$102.33 - $144.73 $3.66 Million - $5.17 Million	35,731 New	35,731 $4.98 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account